Nasdaq Stocks

On May 25, Novavax, Inc. NVAX announced that it has started the phase 1 clinical trial of its coronavirus vaccine candidate, with preliminary results slated to come out in another couple of months. Novavax is among the many biotech companies working toward the development of a C

Latvia is planning to become one of the first countries to launch a coronavirus contact-tracing app using the new toolkit created by Apple, Inc. AAPL and Alphabet, Inc.’s GOOGL Google. Last week, Google and Apple released the initial version of their COVID-19 contact-tracing a

Cerner Corporation CERN recently collaborated with Hospital IQ, which is an intelligent automation company, to lend support to health systems with predictive analytics in order to boost clinical and operational awareness. With this partnership, Cerner is likely to bolster its al

Veeva Systems Inc. VEEV is scheduled to release first-quarter fiscal 2021 results on May 28, after the closing bell.In the last reported quarter, the company delivered a positive earnings surprise of 3.9%. Its earnings surpassed estimates in each of the trailing four quarters, t

South Korea's central bank is expected to cut its policy rate to a record low on Thursday, as the coronavirus pandemic hits exports in the trade-reliant economy and prospects of a second wave of infections cloud the outlook.

Indian stocks will not recoup this year's losses anytime soon and 2020 will mark the worst annual performance in nine years on fears of a deep downturn in the economy and business activity, a Reuters poll of market strategists found.

India's economy is likely to have expanded at its slowest pace in at least eight years in the January-March quarter, partly as a result of the coronavirus clampdown, a Reuters poll predicted.

InvestorPlace - Stock Market News, Stock Advice & Trading Tips

Investors seek growth stocks to capitalize on above-average growth in financials that help these securities grab the market's attention and produce exceptional returns. However, it isn't easy to find a great growth stock.

Investors seek growth stocks to capitalize on above-average growth in financials that help these securities grab the market's attention and produce exceptional returns. However, it isn't easy to find a great growth stock.

Growth investors focus on stocks that are seeing above-average financial growth, as this feature helps these securities garner the market's attention and deliver solid returns. However, it isn't easy to find a great growth stock.

The market expects Perceptron (PRCP) to deliver a year-over-year increase in earnings on flat revenues when it reports results for the quarter ended March 2020. This widely-known consensus outlook is important in assessing the company's earnings picture, but a powerful factor th

Wall Street expects a year-over-year decline in earnings on lower revenues when ProPetro Holding (PUMP) reports results for the quarter ended March 2020. While this widely-known consensus outlook is important in gauging the company's earnings picture, a powerful factor that coul

Wall Street expects a year-over-year increase in earnings on higher revenues when Mesa Labs (MLAB) reports results for the quarter ended March 2020. While this widely-known consensus outlook is important in gauging the company's earnings picture, a powerful factor that could imp

Wall Street expects a year-over-year decline in earnings on higher revenues when Capital Southwest (CSWC) reports results for the quarter ended March 2020. While this widely-known consensus outlook is important in gauging the company's earnings picture, a powerful factor that co

The market expects Iteris (ITI) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2020. This widely-known consensus outlook is important in assessing the company's earnings picture, but a powerful factor that

Celyad SA (CYAD) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is one of the most powerful forces impacting stock prices.

Aduro Biotech (ADRO) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting stock prices -- has triggered this rating change.

Applied Genetic Technologies (AGTC) could be a solid choice for investors given its recent upgrade to a Zacks Rank #1 (Strong Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is one of the most powerful forces impacting stock prices.

Bluebird Bio (BLUE) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is one of the most powerful forces impacting stock prices.